Table 2

Pathological characteristics of colorectal cancer according to tumour location bowel subsite

Pathological featureTotal NCaecumAscending colonHepatic flexureTransverse colonSplenic flexureDescending colonSigmoid colonRectosigmoidRectump Value
Disease stage<0.0001
 I339 (26%)53 (24%)59 (22%)12 (29%)16 (18%)7 (22%)12 (16%)84 (31%)33 (34%)63 (33%)
 II403 (31%)75 (34%)108 (40%)15 (36%)35 (40%)9 (28%)32 (43%)67 (25%)24 (25%)38 (20%)
 III357 (28%)57 (26%)61 (22%)9 (21%)21 (24%)9 (28%)25 (34%)77 (28%)30 (31%)68 (36%)
 IV187 (15%)36 (16%)44 (16%)6 (14%)16 (18%)7 (22%)5 (6.8%)44 (16%)9 (9.4%)20 (11%)
Tumour differentiation<0.0001
 Well to moderate1286 (90%)214 (88%)234 (80%)37 (80%)77 (86%)28 (85%)81 (98%)298 (96%)103 (98%)214 (96%)
 Poor140 (9.8%)28 (12%)58 (20%)9 (20%)13 (14%)5 (15%)2 (2.4%)13 (4.2%)2 (1.9%)10 (4.5%)
Mucinous component<0.0001
 0%836 (62%)116 (49%)138 (48%)18 (45%)41 (48%)17 (52%)57 (71%)217 (75%)71 (75%)161 (79%)
 1–49%340 (25%)82 (35%)93 (33%)10 (25%)27 (31%)12 (36%)16 (20%)52 (18%)19 (20%)29 (14%)
 ≥50%175 (13%)39 (16%)55 (19%)12 (30%)18 (21%)4 (12%)7 (8.8%)22 (7.6%)5 (5.3%)13 (6.4%)
Signet ring cell component<0.0001
 0%1201 (89%)207 (88%)224 (79%)33 (83%)70 (82%)32 (97%)75 (94%)278 (96%)94 (99%)189 (93%)
 1–49%123 (9.1%)27 (11%)50 (18%)7 (18%)12 (14%)1 (3.0%)5 (6.3%)10 (3.4%)1 (1.1%)10 (4.9%)
 ≥50%23 (1.7%)2 (0.9%)11 (3.9%)03 (3.5%)003 (1.0%)04 (2.0%)
  • (%) Indicates the proportion of cases with a specific pathological feature among cancers located in each subsite (caecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, rectosigmoid or rectum). p Values were calculated by the χ2 test.